Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two researchers from the Centre for Tropical Medicine and Global Health were awarded medals by the Royal Society of Tropical Medicine and Hygiene at the 2019 European Congress on Tropical Medicine and International Health. Professor David Warrell was awarded the Sir Patrick Manson Medal, and Dr Samson Kinyanjui the Chalmers Medal.

Professor David Warrell received the highly regarded Manson Medal, the highest prize of the Royal Society of Tropical Medicine, awarded triennially, in recognition to his lifelong work in tropical medicine, notably on malaria, snakebites and rabies. Professor Warrel not only founded the Centre for Tropical Medicine in Oxford, he started the research at the Mahidol Oxford Research Unit in Bangkok, Thailand, in 1979. His research at MORU revolutionised the treatment of severe malaria.
Professor Warrell shares the 2019 Manson Medal with Professor Janet Hemingway from the Liverpool School of Tropical Medicine. Previous award winners include Nick White (2010) and David Weatherall (1998).

Dr Samson Kinyanjui received the Chalmers Medal, awarded to researchers in tropical medicine or international health who obtained their last relevant qualification between 15 and 20 years ago. Dr Kinyanjui received this award in recognition to his work in capacity building and training of scientists in Kenya. Dr Kinyanjui is the Head of IDeAL, the Initiative to Develop African Research Leaders. IDeAL strives to attract young Africans to research and has trained 800 African researchers to date.
Previous award winners include Philip Bejon (2014), Mike English (2008), Nick Day (2006), François Nosten (2002), Bob Snow (1999), Kevin Marsh (1994), Nick White (1993) and David Warrell (1981).

Similar stories

Check-list recommended to improve reporting of microscopy methods and results in malaria studies

MORU Bangkok Publication Research

A study to explore the variations of how microscopy methods are reported in published malaria studies has recommended standardised procedures should be implemented for methodological consistency and comparability of clinical trial outcomes.

Susie Dunachie awarded flagship NIHR career development award

Awards & Appointments MORU Bangkok

Susie Dunachie joins a prestigious group of leading health researchers in the latest cohort of NIHR Global Research Professors. These awards fund research leaders of the future to promote effective translation of research and to strengthen health, public health and care research leadership at the highest academic levels. Research conducted by Global Research Professors directly benefits people in LMICs. A Consultant in Infectious Diseases and Medical Microbiology, Susie works on the development of a vaccine to prevent death from melioidosis in people with type 2 diabetes mellitus in LMICs, and supports vaccine research in Thailand. Congratulations!

The COVID-19 vaccine: do we know enough to end the pandemic?

MORU Bangkok Research

Blog by Rima Shretta. Preliminary efficacy results from three vaccine candidates currently in Phase 3 trials have shown an efficacy of more than 90% against the development of symptomatic COVID-19. While these results are promising, all vaccines are in relatively early stages of testing. A comprehensive and transparent roadmap is urgently needed, to determine how limited doses of the first vaccines to be licensed will be distributed, together with which groups will initially be prioritized.

New study on the risk of Plasmodium vivax parasitaemia after Plasmodium falciparum malaria

MORU Bangkok Publication Research

A new study quantifying the high risk of Plasmodium vivax parasitaemia after treatment of Plasmodium falciparum malaria aims to identify populations in which a policy of universal radical cure, combining artemisinin-based combination therapy with a hypnozoitocidal antimalarial drug, would be most beneficial.

Clare Ling awarded honorary FRCPath

Awards & Appointments SMRU

Dr Clare Ling has been made an honorary Fellow of the Royal College of Pathologists (FRCPath). Currently running Shoklo Malaria Research Unit (SMRU) Microbiology department and supporting the unit’s molecular activities, Clare is a clinical scientist who has worked at SMRU on the Thai-Myanmar border since 2012.

Applicability of COVID-19 vaccine trial results to low-and-middle-income countries

COVID-19 MORU Bangkok

In the next few months, the first Phase 3 COVID-19 vaccine trials – the majority of them in upper-middle or high-income countries and in specific target populations like young adults – will report their results. How relevant will their study results be for low-resource settings?